`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF NEW JERSEY
`CAMDEN VICINAGE
`
`[Doc. No. 89]
`
`CORNERSTONE THERAPEUTICS,
`INC., CORNERSTONE BIOPHARMA,
`INC., and EKR THERAPEUTICS,
`LLC,
`
`Plaintiffs,
`
`v.
`SANDOZ INC.,
`
`Defendant.
`
`Civil No. 13-5723 (NLH/AMD)
`
`ORDER
`comes before the Court by way of
`This matter
`Plaintiffs’ motion for leave to file an amended complaint in
`order (1) to amend the case caption to reflect Cornerstone
`Therapeutics Inc.’s change of corporate name to Chiesi USA,
`Inc.; and (2) to add ACS Dobfar Info S.A. and Sandoz AG as
`
`defendants in this litigation.1 (See generally Plaintiffs’ Brief
`
`in Support of their Motion for Leave to File Amended Complaint
`[Doc. No. 90-10].)
`The Court notes that Defendant asserts that Defendant
`“does not oppose the filing of Plaintiffs’ amended complaint.” 2
`(Sandoz Inc.’s Reply to Plaintiffs’ Motion for Leave to File
`1 The Court shall address Plaintiffs’ related motion to seal by
`separate Order.
`(See generally Notice of Motion to Seal
`Materials [Doc. No. 91].)
`2 The Court shall address Defendant’s related motion to seal by
`separate Order. (See generally Notice of Motion to Seal [Doc.
`No. 100].)
`
`
`
`EKR Therapeutics, LLC Exhibit 2009 Page 1
`
`
`
`Case 1:13-cv-05723-NLH-AMD Document 103 Filed 06/04/14 Page 2 of 2 PageID: 1267
`
`Amended Complaint [Doc. No. 99].) Consequently, the Court
`decides this matter pursuant to Federal Rule of Civil Procedure
`78(b), and for the reasons set forth herein, and for good cause
`shown:
`
`IT IS on this 4th day of June 2014,
`ORDERED that Plaintiffs’ motion for leave to file an
`amended complaint [Doc. No. 89] shall be, and hereby is,
`GRANTED; and it is further
`ORDERED
`that Plaintiffs shall file the amended
`complaint in the form attached to the motion, within fourteen
`(14) days from entry of this Order, and shall serve the amended
`complaint in accordance with the Federal Rules of Civil
`Procedure.
`
`s/ Ann Marie Donio
`ANN MARIE DONIO
`UNITED STATES MAGISTRATE JUDGE
`
`cc: Hon. Noel L. Hillman
`
`2
`
`EKR Therapeutics, LLC Exhibit 2009 Page 2
`
`